منابع مشابه
Treatment of myoclonus with pheneturide.
Twenty-one patients with various forms of myoclonus are presented. Phenacemide was given to five patients with considerable benefit to three, but with serious toxic effects in two. Another acetylurea derivative, pheneturide, was given to 19 patients and was well tolerated. Myoclonus was completely or substantially controlled in 12 patients.
متن کاملTreatment of Propriospinal Myoclonus at Sleep Onset
Dear Editor, Propriospinal myoclonus (PSM) is characterized by jerks arising in axial muscles that spread to more caudal and rostral segments along propriospinal pathways. PSM at sleep onset is a subtype of PSM that occurs during the sleep–awake transition and causes severe sleep-onset insomnia.1 Previous case reports have focused on the etiology and mechanism of PSM, but have not evaluated tre...
متن کاملBotulinum Toxin A for Treatment of Diaphragmatic Myoclonus
Correspondence To the Editor: Diaphragmatic myoclonus, as a typical unusual focal dyskinesia, is characterized by repetitive involuntary synchronous contractions of the diaphragm and other respiratory muscles. [1] Various clinical presentations and difficulties in identifying etiology might lead to its late diagnoses and ineffective treatment in many cases. Botulinum toxin A has a paralyzing ef...
متن کاملOfatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
Opsoclonus-myoclonus syndrome (OMS) may be associated with ANNA-1 (anti-Hu) autoantibodies. The standard treatment with IVIG, steroids, and anti-CD20 monoclonal antibody may fail, and optimal therapy is unknown. A patient developed OMS with high-titer ANNA-1 following recovery from neuroblastoma. She failed standard therapy and had only transient response to rituximab. Treatment with the humani...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurotherapeutics
سال: 2013
ISSN: 1933-7213,1878-7479
DOI: 10.1007/s13311-013-0216-3